Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar;50(1):30-43.
doi: 10.1111/nbu.12725. Epub 2025 Jan 12.

Sarcopenic obesity and brain health: A critical appraisal of the current evidence

Affiliations
Review

Sarcopenic obesity and brain health: A critical appraisal of the current evidence

Uraiporn Booranasuksakul et al. Nutr Bull. 2025 Mar.

Abstract

Sarcopenic obesity (SO) is a body composition phenotype derived from the simultaneous presence in the same individual of an increase in fat mass and a decrease in skeletal muscle mass and/or function. Several protocols for the diagnosis of SO have been proposed in the last two decades making prevalence and disease risk estimates of SO heterogeneous and challenging to interpret. Dementia is a complex neurological disorder that significantly impacts patients, carers and healthcare systems. The identification of risk factors for early cognitive impairment and dementia is key to mitigating the forecasted trends of a 2-fold increase in dementia case numbers over the next two decades worldwide. Excess adiposity and sarcopenia have both been independently associated with risk of cognitive impairment and dementia. Whether SO is associated with a greater risk of cognitive impairment and dementia is currently uncertain. This review critically appraises the current evidence on the association between SO with cognitive outcomes and dementia risk. It also discusses some of the putative biological mechanisms that may link the SO phenotype with alteration of brain functions.

Keywords: cognitive impairment; obesity; sarcopenia; sarcopenic obesity.

PubMed Disclaimer

References

REFERENCES

    1. Ackermans, L.L., Rabou, J., Basrai, M., Schweinlin, A., Bischoff, S., Cussenot, O. et al. (2022) Screening, diagnosis and monitoring of sarcopenia: when to use which tool? Clinical Nutrition ESPEN, 48, 36–44.
    1. Ali, S.A., Begum, T. & Reza, F. (2018) Hormonal influences on cognitive function. Malaysian Journal of Medical Sciences, 25, 31–41.
    1. Arnoldussen, I.A., Kiliaan, A.J. & Gustafson, D.R. (2014) Obesity and dementia: adipokines interact with the brain. European Neuropsychopharmacology, 24, 1982–1999.
    1. Bahat, G. & Erdoğan, T. (2022) Sarcopenia. In: Encyclopedia of gerontology and population aging. Germany: Springer, pp. 4360–4373.
    1. Bathina, S. & Das, U.N. (2015) Brain‐derived neurotrophic factor and its clinical implications. Archives of Medical Science, 11, 1164–1178.

LinkOut - more resources